Ethylene Glycol, min 99%, for synthesis, 25 l, plastic packaging.

4-Dimethoxymethylpyrimidine, 95.0%, 5g

4-Chloro-3-nitrobenzamide>98.0%(GC)5g

Methyl(pyridazin-4-ylmethyl)amine hydrochloride, 98+%, 100mg

N-(2,3-dichlorophenyl)acetimidamide, 98%, 1g

4-Bromo-6-methoxyquinoline, 95.0%, 10g

Oxalic acid solution, ROTI®Volum 0.05 mol/l - 0.1 N, ampoule, 1 piece, plastic packaging.

1,3-Di-tert-butyl-1,3,2-diazaphospholidine 2-Oxide>95.0%(GC)5g

2-Chloro-3-methyl-1,8-naphthyridine, 95%, 250mg

3-[(piperidin-3-yloxy)methyl]pyridine, 95.0%, 5g

tert-Butyl (3-bromocyclobutyl)carbamate, 98%, 5g

2-CHLORO-6,7-DIHYDROQUINOLIN-8(5H)-ONE, 95.0%, 250mg

tert-Butyl 2-amino-6-azaspiro[3.4]octane-6-carboxylate, 95.0%, 250mg